Search
Close this search box.

Clinical Trial: SWOG S1706

SWOG S1706

Status: Open

A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer

S1706 will close to accrual on July 1, 2024